I was not surprised to hear the excuse why not to release final safety ,
It's ironic that efficacy , neve thought , or represented by Bpax to be a issue caused SH a enormous amount I'd VALUE of each share owned , that contributed in completing what appears to be the FIRST PROVEN safety tral of its kind EVER
In short , one has to ask , was efficacy set up to fail ? If so this is a very well thought out CON !
Safety appears to be proven
No value paced on Libigel considered in the MERGER
And there is a excuse WHY ,
What's even more disgusting , is they will impose a RS to fk us more than they have already
Say class action ! Jmho